FNY Investment Advisers’s Takeda Pharmaceutical TAK Stock Holding History

FNY Investment Advisers’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,500	Closed	-$37K	–	1183
2025 Q1	$37K	Buy	+2,500	New	+$35K	0.02%	326
2024 Q4	–	Sell	-87,594	Closed	-$1.25M	–	926
2024 Q3	$1.25M	Buy	+87,594	New	+$1.24M	0.6%	50
2024 Q2	–	Sell	-61,956	Closed	-$860	–	797
2024 Q1	$860	Buy	+61,956	New	+$901K	0.52%	48
2023 Q2	–	Sell	-20,000	Closed	-$329K	–	694
2023 Q1	$329K	Hold	20,000	–	–	0.38%	50
2022 Q4	$312K	Sell	20,000 -25,000	-56%	-$349K	0.44%	51
2022 Q3	$583K	Buy	+45,000	New	+$626K	0.4%	54
2022 Q1	–	Sell	-169,500	Closed	-$2.31M	–	898
2021 Q4	$2.31M	Sell	169,500 -121,253	-42%	-$1.7M	1.24%	12
2021 Q3	$4.76M	Buy	290,753 +126,143	+77%	+$2.12M	2.21%	6
2021 Q2	$2.77M	Buy	164,610 +61,622	+60%	+$1.05M	1.11%	18
2021 Q1	$1.88M	Buy	+102,988	New	+$1.85M	0.7%	37
2020 Q4	–	Sell	-51,200	Closed	-$913K	–	904
2020 Q3	$913K	Buy	+51,200	New	+$932K	0.39%	69
2020 Q2	–	Sell	-18,000	Closed	-$273K	–	590
2020 Q1	$273K	Buy	+18,000	New	+$326K	0.21%	95
2019 Q4	–	Sell	-1	Closed	–	–	1061
2019 Q3	$0	Sell	1 -2,199	-100%	-$38K	﹤0.01%	1169
2019 Q2	$38K	Sell	2,200 -81,946	-97%	-$1.49M	0.01%	401
2019 Q1	$1.71M	Buy	+84,146	New	+$1.69M	0.59%	31

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

FNY Investment Advisers's TAK Position: Q2 2025 in Review

FNY Investment Advisers sold out of Takeda Pharmaceutical (TAK) in Q2 2025, closing a stake of 2,500 shares — an estimated $37K sold.

FNY Investment Advisers first reported a position in TAK in Q1 2019 and held it in 15 quarters. The position peaked at $4.76M in Q3 2021. 315 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

FNY Investment Advisers reported no remaining Takeda Pharmaceutical position as of Q2 2025 after selling out during the quarter.
FNY Investment Advisers sold 2,500 Takeda Pharmaceutical shares in Q2 2025, an estimated $37K.
FNY Investment Advisers first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 15 quarters.
FNY Investment Advisers's Takeda Pharmaceutical position peaked at $4.76M in Q3 2021.
315 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on FNY Investment Advisers's 13F filing for Q2 2025, filed 30 Jul 2025.